Funded Health Care Startups in Hyderabad
Among the 15 most recent Health Care funding events in Hyderabad, Andhra Pradesh, the largest disclosed round is Omega Hospitals at $60M (2024-06-19).
Among the 15 most recent Health Care funding events in Hyderabad, Andhra Pradesh, the largest disclosed round is Omega Hospitals at $60M (2024-06-19). That figure dwarfs the rest of the disclosed amounts in this set, with the next-largest disclosures at $50M for Oasis Fertility (2022-08-25) and $24M for NephroPlus (2021-12-13). A clear funding-size skew also shows up at the low end: the smallest disclosed amount is $120K for Moderate (2025-02-20), while TakeMe2Space at $630K (2025-03-04) and Althion at $430K (2024-11-28) sit just above the sub-$1M band.
The timing cluster is concentrated in late 2024 to early 2025: 6 of the 15 rounds fall between 2024-09-09 and 2025-06-23, including Utopia Therapeutics at $2M (2025-06-23). Stage classification is mixed, with “Series Unknown” appearing in 2 entries (Omega Hospitals on 2024-06-19 and Fleming Laboratories on 2023-12-19) and “undisclosed” appearing once (Fitday on 2024-09-09).
Most recent rounds
15 shownRelated listings
Frequently asked
What’s the largest disclosed round in this Hyderabad Health Care list, and how does it stack up against the next-largest disclosed deals?
Omega Hospitals has the largest disclosed amount at $60M on 2024-06-19, and it meaningfully exceeds the next-largest disclosed rounds of $50M (Oasis Fertility, 2022-08-25) and $24M (NephroPlus, 2021-12-13). No other disclosed amount in the table is close to the $60M figure.
Are there noticeable clusters in the round dates for Hyderabad-based Health Care companies here?
Yes. Six of the 15 rounds land between 2024-09-09 and 2025-06-23, including Utopia Therapeutics ($2M, 2025-06-23), TakeMe2Space ($630K, 2025-03-04), and Althion ($430K, 2024-11-28). This contrasts with a broader earlier spread starting from 2021-12-13 (NephroPlus).
Which stage labels dominate, and how often are stage amounts missing or unclassified?
Seed appears frequently (Utopia Therapeutics on 2025-06-23, Althion on 2024-11-28, Portl on 2024-05-23, Monitra Healthcare on 2023-12-19, plus Fitday on 2024-09-09). Stage is “Series Unknown” for 2 entries (Omega Hospitals, 2024-06-19; Fleming Laboratories, 2023-12-19), and “undisclosed” appears once (Fitday, 2024-09-09).
Is the list skewed toward very small early rounds, and what are the low-end benchmarks in disclosed amounts?
Disclosed amounts include a very low outlier at $120K for Moderate (2025-02-20). Several deals cluster below $1M as well, such as TakeMe2Space at $630K (2025-03-04) and Althion at $430K (2024-11-28), before moving up to multi-million rounds like Portl’s $3M (2024-05-23).
Are there other outliers besides the $60M maximum, especially around the mid-to-late funding range?
At the high end, Oasis Fertility’s $50M (2022-08-25) and NephroPlus’s $24M (2021-12-13) stand well above the mid-pack, including $20M for StanPlus (2022-01-24) and $13M for Fleming Laboratories (2023-12-19). In contrast, Fitday has an undisclosed amount on 2024-09-09, making its position relative to the rest unquantifiable from disclosed data.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.